Targeted and reversible cancer cell-binding DNA nanoparticles

被引:2
|
作者
Ruff, Laura E. [1 ]
Marciniak, Jennifer Y. [1 ]
Sanchez, Ana B. [1 ]
Esener, Sadik C. [2 ]
Messmer, Bradley T. [1 ]
机构
[1] Univ Calif San Diego, UCSD Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
affinity reagent; DNA; nanoparticle; pancreatic cancer; NUCLEIC-ACID; ANTIPROLIFERATIVE ACTIVITY; APTAMERS; OLIGONUCLEOTIDES; MOTIF; MOLECULES; SELECTION; LIGANDS;
D O I
10.1515/ntrev-2014-0010
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
DNA nanoparticles (DeNAno) produced by rolling circle replication of circular oligonucleotide templates are a novel format for the selection of cell-binding reagents from randomized libraries. DeNAno particles consist of several hundred concatemers and can leverage that multivalency to bind to complex surfaces such as cells. In this study, an iterative bio-panning approach was used to recover particles that bound to the mouse pancreatic cancer line, Panc-02. These particles shared a primary sequence motif. Hybridization of a locked nucleic acid complimentary to this motif both inhibited cell binding and released pre-bound DeNAno particles from the cells. The monomeric form of one of the selected sequences was unable to compete with the cognate particle, consistent with a low-affinity, but high-avidity, type interaction. DeNAno library selection against cancer or other cell types can, thus, yield novel cell binding agents without a priori knowledge of particular cell surface molecules.
引用
收藏
页码:569 / 578
页数:10
相关论文
共 50 条
  • [1] Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
    R Kircheis
    A Kichler
    G Wallner
    M Kursa
    M Ogris
    T Felzmann
    M Buchberger
    E Wagner
    Gene Therapy, 1997, 4 : 409 - 418
  • [2] Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
    Kircheis, R
    Kichler, A
    Wallner, G
    Kursa, M
    Ogris, M
    Felzmann, T
    Buchberger, M
    Wagner, E
    GENE THERAPY, 1997, 4 (05) : 409 - 418
  • [3] DIFFERENCES IN EUKARYOTIC CELL-BINDING OF PSEUDOMONAS
    CERVIN, MA
    SIMPSON, DA
    SMITH, AL
    LORY, S
    MICROBIAL PATHOGENESIS, 1994, 17 (05) : 291 - 299
  • [4] REQUIREMENT FOR A BEND IN CELL-BINDING PEPTIDES
    GOUGH, CA
    QIAN, JJ
    WEDRYCHOWSKA, A
    BHATNAGAR, R
    FASEB JOURNAL, 1995, 9 (06): : A1427 - A1427
  • [5] Reversible binding of fluorescent proteins at DNA-gold nanoparticles
    Hazarika, Pompi
    Kukolka, Florian
    Niemeyer, Christof M.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (41) : 6827 - 6830
  • [6] Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus
    Chan, TM
    Leung, JKH
    Ho, SKN
    Yung, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05): : 1219 - 1229
  • [7] A CELL-BINDING, IMMUNOGLOBULIN-LIKE PROTEIN FROM HUMAN-PLASMA .2. CELL-BINDING ACTIVITY
    FUKAMIZU, H
    OHORI, K
    NAITO, Y
    HORIUCHI, K
    FUJIMOTO, D
    JOURNAL OF BIOCHEMISTRY, 1986, 100 (04): : 843 - 848
  • [8] BACTERIA TEMPLATE THEIR OWN CELL-BINDING POLYMERS
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (20) : 31 - 31
  • [9] Identification of Cell-Binding Adhesins of Leptospira interrogans
    Evangelista, Karen V.
    Hahn, Beth
    Wunder, Elsio A., Jr.
    Ko, Albert I.
    Haake, David A.
    Coburn, Jenifer
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (10):
  • [10] Preclinical evaluation of the breast cancer cell-binding peptide, p160
    Askoxylakis, V
    Zitzmann, S
    Mier, W
    Graham, K
    Krämer, S
    von Wegner, F
    Fink, RHA
    Schwab, M
    Eisenhut, M
    Haberkorn, U
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6705 - 6712